SORIATANE Drug Patent Profile
✉ Email this page to a colleague
When do Soriatane patents expire, and when can generic versions of Soriatane launch?
Soriatane is a drug marketed by Stiefel Labs Inc and is included in one NDA.
The generic ingredient in SORIATANE is acitretin. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acitretin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Soriatane
A generic version of SORIATANE was approved as acitretin by BARR LABS INC on April 4th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SORIATANE?
- What are the global sales for SORIATANE?
- What is Average Wholesale Price for SORIATANE?
Summary for SORIATANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 119 |
| Clinical Trials: | 5 |
| Patent Applications: | 5,252 |
| Drug Prices: | Drug price information for SORIATANE |
| What excipients (inactive ingredients) are in SORIATANE? | SORIATANE excipients list |
| DailyMed Link: | SORIATANE at DailyMed |
Recent Clinical Trials for SORIATANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tulane University | Phase 2 |
| Assistance Publique - Hôpitaux de Paris | Phase 2 |
| University of Arizona | Phase 2 |
US Patents and Regulatory Information for SORIATANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-001 | Oct 28, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-002 | Oct 28, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-003 | Aug 6, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-004 | Aug 6, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
